Alembic Pharma gets USFDA nod for Desonide Ointment
Posted by
www.biotecnika.org
Desonide Ointment, 0.05 per cent, is a low potency corticosteroid
indicated for the relief of the inflammatory and pruritic
manifestations of corticosteroid responsive dermatoses.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-desonide-ointment/articleshow/71736150.cms
Subscribe to:
Post Comments (Atom)
Post a Comment